Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Stock Rises on Report of Bidders

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Gen-Probe closed up 9 percent on Wednesday after The Wall Street Journal reported on its website that a few bidders have emerged to buy the company.

The Journal cited people familiar with the bidding process in reporting that Novartis, Life Technologies, and Thermo Fisher Scientific have emerged as initial bidders. All three were listed as potential bidders by Bloomberg, when it reported last month that Gen-Probe had hired Morgan Stanley to seek a buyer.

The WSJ also had reported Wednesday that Thermo Fisher also is a leading contender to buy Phadia, a privately held allergy and autoimmunity testing firm that could fetch as much as $3 billion. Following that report, Thermo Fisher announced Thursday that it has signed a definitive agreement to acquire Phadia for €2.47 billion ($3.5 billion).

Gen-Probe recently reported first-quarter revenue growth of 6 percent to $143 million. It has a market cap of around $4.1 billion.

In early Thursday trade on the Nasdaq, shares of Gen-Probe pulled back 2 percent to $84.53.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.